- HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
- Key Figures 15.05.2024
- HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
- Key Figures 30.04.2024
- Key Figures 15.04.2024
- Key Figures 31.03.2024
- HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
- Key Figures 15.03.2024
- Key Figures 29.02.2024
More ▼
Key statistics
On Wednesday, HBM Healthcare Investments AG (HBMN:SWX) closed at 202.00, -3.81% below its 52-week high of 210.00, set on Jun 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 6.96m |
---|---|
Market cap | 1.41bn CHF |
Total assets | 1.60bn CHF |
Total expense ratio | 0.07% |
High | 202.50 |
Low | 197.00 |
Previous close | 202.00 |
Average volume | 4.14k |
---|---|
YTD Change | +10.62% |
Beta | 0.9734 |
Diluted NAV (est) | 229.31 |
Diluted NAV (last pub) | 229.31 |
Premium/Discount | -- |
Net Gearing | 0.00% |
Annual div (ADY) | 7.50 CHF |
---|---|
Annual div yield (ADY) | 3.79% |
Div ex-date | Aug 03 2023 |
Div pay-date | Aug 07 2023 |
Data delayed at least 15 minutes, as of May 22 2024 16:30 BST.
More ▼